HCA Healthcare, Inc. (HCA) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Win.
70/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseHCA / S&P -17.45% / 15.20% |
LoseHCA / S&P HCA unavailable / 15.00% |
LoseHCA / S&P HCA unavailable / 50.40% |
| 2026-Q12/3 |
WinHCA / S&P 1.52% / -4.33% |
LoseHCA / S&P 6.71% / 11.30% |
WinHCA / S&P 29.12% / 27.70% |
| 2025-Q42/3 |
WinHCA / S&P 9.70% / 2.65% |
LoseHCA / S&P 7.08% / 9.00% |
WinHCA / S&P 28.99% / 13.40% |
| 2025-Q33/3 |
WinHCA / S&P 11.45% / 8.12% |
WinHCA / S&P 6.82% / 4.61% |
WinHCA / S&P 16.32% / 13.45% |
| 2025-Q23/3 |
WinHCA / S&P 11.08% / 10.94% |
WinHCA / S&P 6.37% / 4.83% |
WinHCA / S&P 11.85% / 10.63% |
| 2025-Q13/3 |
WinHCA / S&P 15.39% / -4.27% |
WinHCA / S&P 7.30% / 4.98% |
WinHCA / S&P 12.28% / 10.57% |
| 2024-Q42/3 |
LoseHCA / S&P -25.99% / 2.41% |
WinHCA / S&P 8.67% / 5.25% |
WinHCA / S&P 15.94% / 6.15% |
| 2024-Q33/3 |
WinHCA / S&P 26.72% / 5.89% |
WinHCA / S&P 10.23% / 5.89% |
WinHCA / S&P 9.94% / 6.11% |
| 2024-Q22/3 |
LoseHCA / S&P -3.49% / 4.28% |
WinHCA / S&P 10.38% / 5.38% |
WinHCA / S&P 5.14% / 5.12% |
| 2024-Q12/3 |
WinHCA / S&P 23.47% / 10.56% |
WinHCA / S&P 9.59% / 5.71% |
LoseHCA / S&P 0.96% / 5.59% |
| 2023-Q41/3 |
LoseHCA / S&P 10.29% / 11.69% |
WinHCA / S&P 7.86% / 6.81% |
LoseHCA / S&P -0.94% / 7.78% |
| 2023-Q31/3 |
LoseHCA / S&P -18.76% / -3.27% |
LoseHCA / S&P 5.62% / 7.52% |
WinHCA / S&P 14.42% / -5.03% |
| 2023-Q22/3 |
WinHCA / S&P 15.34% / 8.74% |
LoseHCA / S&P 3.02% / 9.50% |
WinHCA / S&P -2.60% / -8.57% |
| 2023-Q12/3 |
WinHCA / S&P 10.15% / 7.50% |
LoseHCA / S&P 1.94% / 10.77% |
WinHCA / S&P -6.55% / -15.69% |
| 2022-Q42/3 |
WinHCA / S&P 30.86% / 7.56% |
LoseHCA / S&P 2.52% / 11.88% |
WinHCA / S&P -9.89% / -17.99% |
| 2022-Q31/3 |
WinHCA / S&P 9.65% / -4.88% |
LoseHCA / S&P 3.14% / 13.47% |
LoseHCA / S&P -9.98% / -1.41% |
| 2022-Q21/3 |
LoseHCA / S&P -32.73% / -16.10% |
LoseHCA / S&P 7.30% / 13.71% |
WinHCA / S&P 42.36% / 11.04% |
| 2022-Q12/3 |
WinHCA / S&P -2.25% / -4.60% |
LoseHCA / S&P 13.43% / 15.97% |
WinHCA / S&P 58.55% / 42.23% |
| 2021-Q40/3 |
LoseHCA / S&P 6.06% / 11.03% |
LoseHCA / S&P 14.01% / 15.00% |
LoseHCA / S&P 94.06% / 96.40% |
| 2021-Q33/3 |
WinHCA / S&P 17.63% / 0.58% |
WinHCA / S&P 14.22% / 10.77% |
WinHCA / S&P 98.58% / 69.42% |
| 2021-Q22/3 |
WinHCA / S&P 10.02% / 8.55% |
WinHCA / S&P 11.71% / 6.58% |
LoseHCA / S&P 50.41% / 51.81% |
| 2021-Q13/3 |
WinHCA / S&P 14.81% / 6.17% |
WinHCA / S&P 1.88% / -1.06% |
WinHCA / S&P 52.33% / 7.39% |
| 2020-Q43/3 |
WinHCA / S&P 32.19% / 12.15% |
WinHCA / S&P 0.38% / -3.72% |
WinHCA / S&P 8.64% / -33.42% |
| 2020-Q33/3 |
WinHCA / S&P 28.46% / 8.93% |
WinHCA / S&P 1.35% / -2.04% |
WinHCA / S&P -1.00% / -27.10% |
| 2020-Q22/3 |
LoseHCA / S&P 8.02% / 20.54% |
WinHCA / S&P 2.67% / -0.46% |
WinHCA / S&P -6.55% / -27.11% |
| 2020-Q11/3 |
LoseHCA / S&P -39.01% / -19.60% |
WinHCA / S&P 8.18% / 3.47% |
LoseHCA / S&P -15.80% / -14.75% |
| 2019-Q42/3 |
WinHCA / S&P 23.10% / 9.07% |
WinHCA / S&P 9.98% / 5.36% |
LoseHCA / S&P -5.45% / 2.99% |
| 2019-Q32/3 |
LoseHCA / S&P -10.62% / 1.70% |
WinHCA / S&P 8.97% / 5.02% |
WinHCA / S&P 11.62% / 0.21% |
| 2019-Q22/3 |
LoseHCA / S&P 4.01% / 4.30% |
WinHCA / S&P 8.04% / 6.64% |
WinHCA / S&P 30.57% / 8.65% |
| 2019-Q11/3 |
LoseHCA / S&P 5.07% / 13.65% |
LoseHCA / S&P 7.56% / 8.12% |
WinHCA / S&P 41.27% / 14.29% |
| 2018-Q42/3 |
WinHCA / S&P -10.33% / -13.52% |
LoseHCA / S&P HCA unavailable / 9.05% |
WinHCA / S&P 78.99% / 18.23% |
| 2018-Q32/3 |
WinHCA / S&P 35.96% / 7.71% |
LoseHCA / S&P HCA unavailable / 10.21% |
WinHCA / S&P 27.67% / 19.06% |
| 2018-Q21/3 |
WinHCA / S&P 6.13% / 3.43% |
LoseHCA / S&P HCA unavailable / 9.03% |
LoseHCA / S&P 6.71% / 14.46% |
| 2018-Q11/3 |
WinHCA / S&P 10.81% / -0.76% |
LoseHCA / S&P HCA unavailable / 7.68% |
LoseHCA / S&P 0.54% / 12.46% |
| 2017-Q41/3 |
WinHCA / S&P 10.37% / 6.64% |
LoseHCA / S&P HCA unavailable / 7.03% |
LoseHCA / S&P -18.49% / 13.82% |
| 2017-Q30/3 |
LoseHCA / S&P -8.73% / 4.48% |
LoseHCA / S&P HCA unavailable / 5.68% |
LoseHCA / S&P 10.92% / 17.57% |
| 2017-Q21/3 |
LoseHCA / S&P -2.01% / 3.09% |
LoseHCA / S&P HCA unavailable / 4.83% |
WinHCA / S&P 28.89% / 17.74% |
| 2017-Q12/3 |
WinHCA / S&P 20.22% / 6.07% |
LoseHCA / S&P HCA unavailable / 3.67% |
WinHCA / S&P 38.42% / 13.32% |
| 2016-Q41/3 |
LoseHCA / S&P -2.13% / 3.82% |
LoseHCA / S&P HCA unavailable / 2.09% |
WinHCA / S&P 46.59% / 7.05% |
| 2016-Q31/3 |
LoseHCA / S&P -1.79% / 3.85% |
LoseHCA / S&P HCA unavailable / 0.20% |
WinHCA / S&P 32.49% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | HCA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 4.51% | 20.78% |
| Annualized return | 4.51% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | HCA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 73.08% | 83.14% |
| Annualized return | 11.60% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | HCA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 502.31% | 319.30% |
| Annualized return | 19.67% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| Surgery Partners, Inc. (SGRY) | United States | $1.860B | -24.80 |
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |